The role of height-associated loci identified in genome wide association studies in the determination of pediatric stature

Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA.
BMC Medical Genetics (Impact Factor: 2.45). 06/2010; 11:96. DOI: 10.1186/1471-2350-11-96
Source: PubMed

ABSTRACT Human height is considered highly heritable and correlated with certain disorders, such as type 2 diabetes and cancer. Despite environmental influences, genetic factors are known to play an important role in stature determination. A number of genetic determinants of adult height have already been established through genome wide association studies.
To examine 51 single nucleotide polymorphisms (SNPs) corresponding to the 46 previously reported genomic loci for height in 8,184 European American children with height measurements. We leveraged genotyping data from our ongoing GWA study of height variation in children in order to query the 51 SNPs in this pediatric cohort.
Sixteen of these SNPs yielded at least nominally significant association to height, representing fifteen different loci including EFEMP1-PNPT1, GPR126, C6orf173, SPAG17, Histone class 1, HLA class III and GDF5-UQCC. Other loci revealed no evidence for association, including HMGA1 and HMGA2. For the 16 associated variants, the genotype score explained 1.64% of the total variation for height z-score.
Among 46 loci that have been reported to associate with adult height to date, at least 15 also contribute to the determination of height in childhood.


Available from: Rosetta Chiavacci, May 20, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: Adipocyte differentiation is key to determining the number of adipocytes during the development of obesity. Recent studies have shown that growth differentiation factor-5 (GDF5) promotes brown adipogenesis, however its role in white adipogenesis is still uncertain. The aim of the present study was to investigate the effect of GDF5 on white adipogenesis using 3T3-L1 preadipocyte model. In the present study, GDF5 was found to be differentially regulated during adipocyte differentiation. GDF5 protein increased the differentiation of 3T3-L1 preadipocytes, especially when these cells were exposed to hormone cocktails without insulin. During adipogenesis, GDF5 enhanced the expression of genes related to adipocyte differentiation and caused cells to enter the S phase. Short-hairpin-RNA knockdown of GDF5 in 3T3-L1 cells was found to prevent adipogenesis induced by a standard hormone cocktail and to downregulate the expression of adipocyte genes and proteins, this impairment could be partly rescued by GDF5 protein. Collectively, these results suggest that GDF5 can promote progression of the cell-cycle and increase numbers of cells in S phase, GDF5 might play a critical role in 3T3-L1 preadipocyte differentiation.
    Archives of Biochemistry and Biophysics 10/2014; DOI:10.1016/ · 3.04 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Idiopathic scoliosis is the most common pediatric spinal deformity affecting 1% to 3% of the population, and adolescent idiopathic scoliosis (AIS) accounts for approximately 80% of these cases; however, the etiology and pathogenesis of AIS are still uncertain. The current study aims to identify the relationship between G protein-coupled receptor 126 (GPR126) gene and AIS predisposition, to identify the relationship between the genotypes of the GPR126 SNPs and the clinical phenotypes of AIS. We conducted a case-control study and genotyped twenty SNPs of GPR126 gene including ten exonic SNPs and ten intronic polymorphisms in 352 Chinese sporadic AIS patients and 149 healthy controls. We provided evidence for strong association of three intronic SNPs of the GPR126 gene with AIS susceptibility: rs6570507 A>G (p=0.0035, OR=1.729), rs7774095 A>C (p=0.0078, OR=1.687), and rs7755109 A>G (p=0.0078, OR=1.687). However, we did not identify any significant association between ten exonic SNPs of GPR126 and AIS. Linkage disequilibrium analysis indicated that rs7774095 A>C and rs7755109 A>G could be parsed into one block. The association between the intronic haplotype and AIS was further confirmed in an independent population with 110 AIS individuals and 130 healthy controls (p=0.046, OR=1.680). Furthermore, molecular mechanisms underlying intronic SNP regulation of GPR126 gene were studied. Although intronic SNPs associated with AIS didn't influence GPR126 mRNA alternative splicing, there was a strong association of rs7755109 A>G with decreased GPR126 mRNA level and protein levels. Our findings indicate that genetic variants of GPR126 gene are associated with AIS susceptibility in Chinese populations. The genetic association of GPR126 gene and AIS might provide valuable insights into the pathogenesis of adolescent idiopathic scoliosis. Copyright © 2014. Published by Elsevier Inc.
    Genomics 12/2014; 105(2). DOI:10.1016/j.ygeno.2014.11.009 · 2.79 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Rationale: Most genomic studies of lung function have used phenotypic data derived from a single time-point (e.g., disease/not) without considering the dynamic progression of a chronic disease. Objectives: To characterize lung function change over time in asthmatics and identify genetic contributors to a longitudinal phenotype. Methods: We present a method that models longitudinal FEV1 (forced expiratory volume in 1 second) data, collected from 1041 asthmatic children who participated in the Childhood Asthma Management Program (CAMP). This longitudinal progression model was built using population-based nonlinear mixed-effects modeling with an exponential structure and the determinants of age and height. Measurements and Main Results: We found ethnicity was a key covariate for FEV1 level. Budesonide-treated asthmatic children had a slight but significant effect on FEV1 when compared to those treated with placebo or nedocromil (p<0.001). A genome-wide association study identified seven SNPs nominally associated with longitudinal lung function phenotypes in 581 Caucasian CAMP subjects [p<10-4 in the placebo (“discovery”) and p<0.05 in the nedocromil treatment (“replication”) group]. Using ChIP-seq and RNA-seq data, we found that some of the associated variants were in strong enhancer regions in human lung fibroblasts and may affect gene expression in human lung tissue. Genetic mapping restricted to genome-wide enhancer SNPs in lung fibroblasts revealed a highly significant variant (rs6763931; p=4x10-6, FDR<0.05). Conclusions: This study offers a strategy to explore the genetic determinants of longitudinal phenotypes, provide a comprehensive picture of disease pathophysiology and suggest potential treatment targets.
    American Journal of Respiratory and Critical Care Medicine 08/2014; 190(6). DOI:10.1164/rccm.201403-0460OC · 11.99 Impact Factor